Yahoo Lifestyle

Why wait 'til Prime Day? Grab these under-$10 deals from Macy's, Kohl's and more today
Lifestyle 2 weeks ago
Why wait 'til Prime Day? Grab these under-$10 deals from Macy's, Kohl's and more today
Full Coverage

These trending 'rich mom' shorts are chic, a celebrity fave and as comfy as PJs
Lifestyle 2 weeks ago
These trending 'rich mom' shorts are chic, a celebrity fave and as comfy as PJs
Full Coverage

Michael Kors is selling a $558 tote for just $87, and fans say it's 'gorgeous'
Lifestyle 2 weeks ago
Michael Kors is selling a $558 tote for just $87, and fans say it's 'gorgeous'
Full Coverage

2025 NBA Draft: How to watch, start time, top picks and more
Lifestyle 2 weeks ago
2025 NBA Draft: How to watch, start time, top picks and more
Full Coverage

Trending

1. Joann's closing
2. Texas Tech basketball
3. UNC basketball
4. Monster Hunter Wilds
5. Ketamine
6. Macron
7. UPMC Memorial shooting
8. Eagles
9. Hims stock
10. Joel Embiid

Popular News

BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
2 weeks ago
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulation und Behandlung von Typ-2-Diabetes sowie präklinische Daten für ein neues Amylin-Analogon bei den 85 Wissenschaftlichen Sitzungen der American Diabetes Association

The mortgage market hopes for rate cuts amid war moves
2 weeks ago
The mortgage market hopes for rate cuts amid war moves

Ukraine returns bodies of 3 Russian soldiers repatriated as ...
2 weeks ago
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry says

BrightGene presenteert positieve fase 2 gegevens voor de dua...
2 weeks ago
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbeheersing en type 2 diabetes, en preklinische gegevens voor een nieuw amylin-analoog tijdens de 85e wetenschappelijke sessies van de American Diabetes Association

BrightGene présente des données positives de phase 2 pour so...
2 weeks ago
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la gestion du poids et le diabète de type 2, ainsi que des données précliniques pour un nouvel analogue de l'amylin, lors de la 85 e édition des Sessions Scientifiques de l'American Diabetes Association
About Us · Contact Us · Terms & Conditions · Help · Privacy ·

© Latest News Search Engine - Global and Local Breaking News 2025. All rights are reserved